granocyte 34 millionen ie/ml
antepsin 1 g tablets
chugai pharma france - sucralfate - tablet - 1 gram(s) - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); sucralfate
antepsin 1 g/5 ml oral suspension
chugai pharma france - sucralfate - oral suspension - 1 g/5ml - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); sucralfate
bleo15k
bleomycin sulfate -
dbl bleomycin
hospira australia pty ltd - bleomycin sulfate -
cipla bleomycin 15k bleomycin sulfate 15000 iu powder for injection vial
cipla australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: sodium hydroxide; hydrochloric acid - palliation and treatment adjuvant to surgery and radiation therapy of the following neoplasms: squamous cell carcinoma of the skin, head and neck, and oesophagus (primary indication). squamous cell carcinoma of the larynx, penis and uterine cervix. squamous cell carcinoma of the bronchus (response infrequent). choriocarcinoma and embryonal cell carcinoma of the testis. advanced hodgkin's disease and other lymphomas. mycosis fungoides note. use of bleomycin after radiation therapy is less successful than use before radiation therapy. bleomycin is bone marrow sparing and may be used when other cytotoxic agents are contraindicated.
procytox tab 25mg tablet
baxter corporation - cyclophosphamide - tablet - 25mg - cyclophosphamide 25mg - antineoplastic agents
procytox tab 50mg tablet
baxter corporation - cyclophosphamide - tablet - 50mg - cyclophosphamide 50mg - antineoplastic agents
procytox powder for solution
baxter corporation - cyclophosphamide - powder for solution - 200mg - cyclophosphamide 200mg - antineoplastic agents
procytox powder for solution
baxter corporation - cyclophosphamide - powder for solution - 500mg - cyclophosphamide 500mg - antineoplastic agents